SWITCH-IG Trademark

Trademark Overview


On Thursday, July 1, 2021, a trademark application was filed for SWITCH-IG with the United States Patent and Trademark Office. The USPTO has given the SWITCH-IG trademark a serial number of 90805830. The federal status of this trademark filing is REGISTERED as of Tuesday, May 7, 2024. This trademark is owned by Chugai Seiyaku Kabushiki Kaisha. The SWITCH-IG trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for use in the treatment or prevention of infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use
switch-ig

General Information


Serial Number90805830
Word MarkSWITCH-IG
Filing DateThursday, July 1, 2021
Status700 - REGISTERED
Status DateTuesday, May 7, 2024
Registration Number7381207
Registration DateTuesday, May 7, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for use in the treatment or prevention of infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, pregnancy, childbirth and the puerperium, and congenital malformations, deformations and chromosomal abnormalities, for medical and pharmaceutical use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 13, 2021
Primary Code005
First Use Anywhere DateMonday, November 30, 2020
First Use In Commerce DateMonday, November 30, 2020

Trademark Owner History


Party NameChugai Seiyaku Kabushiki Kaisha
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 115-8543
JP

Party NameChugai Seiyaku Kabushiki Kaisha
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 115-8543
JP

Party NameChugai Seiyaku Kabushiki Kaisha
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 115-8543
JP

Trademark Events


Event DateEvent Description
Monday, July 5, 2021NEW APPLICATION ENTERED
Monday, September 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 23, 2022ASSIGNED TO EXAMINER
Wednesday, March 23, 2022NON-FINAL ACTION WRITTEN
Wednesday, March 23, 2022NON-FINAL ACTION E-MAILED
Wednesday, March 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 10, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, June 10, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 17, 2022ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, June 22, 2022ELECTRONIC RECORD REVIEW COMPLETE
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, February 1, 2023DIVISIONAL REQUEST RECEIVED
Wednesday, February 1, 2023TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, February 1, 2023SOU EXTENSION 1 FILED
Wednesday, February 1, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 16, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 11, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 3, 2023DIVISIONAL PROCESSING COMPLETE
Wednesday, May 3, 2023SOU EXTENSION 1 GRANTED
Thursday, May 4, 2023CORRECTED NOA E-MAILED
Monday, September 11, 2023SOU EXTENSION 2 FILED
Monday, September 11, 2023SOU EXTENSION 2 GRANTED
Wednesday, September 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU EXTENSION 3 FILED
Wednesday, March 13, 2024USE AMENDMENT FILED
Wednesday, March 13, 2024TEAS STATEMENT OF USE RECEIVED
Monday, April 1, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 2, 2024SOU EXTENSION 3 GRANTED
Tuesday, April 2, 2024STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 3, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, April 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 2, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 7, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, May 7, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED